Trends and outcomes following total artificial heart as bridge to transplant from the UNOS database.

Garrett N Coyan Lauren V HuckabyCarlos E Diaz-CastrillonAlyssa M MiguelinoArman Kilic

Published in: Journal of cardiac surgery (2022)

Patients undergoing BTT with TAH demonstrate acceptable waitlist survival and good 1-year survival. While utilization initially increased as a BTT therapy, there has been a plateau in relative utilization. Individual patient and transplantation center factors deserve further investigation to determine the ideal population for this therapy.

Keyphrases

patients undergoing
heart failure
free survival
cell therapy
stem cells
emergency department
adverse drug
replacement therapy
drug induced